This report covers: Sequencing, Microarray, PCR, Nucleic Acid Extraction and Purification, Diagnostic Test, Genetic Test, Newborn Screening, Preimplantation Testing, Prenatal Testing, Carrier Testing, Molecular Test, Chromosomal Test, Biochemical Test, Diagnostic, Drug Discovery, Precision Medicine, Research Centers, Hospitals and Clinics, Pharmaceutical Companies and Others

1. www.visiongain.com/pharma Page116
Global Genomics Market Report 2018-2028:Sequencing, Microarray, PCR, Nucleic
Acid Extraction and Purification, Diagnostic Test, Genetic Test, Newborn Screening,
Preimplantation Testing, Prenatal Testing, Carrier Testing, Molecular Test, Chromosomal Test,
Biochemical Test, Diagnostic, Drug Discovery, Precision Medicine, Research Centers, Hospitals
and Clinics, Pharmaceutical Companies and Others
By End-user 2023 2024 2025 2026 2027 2028 CAGR
Research Centers ($bn) 0.27 0.29 0.32 0.36 0.39 0.43 9.7%
AGR (%) 9.7% 10.0% 10.2% 10.2% 10.3% 10.1%
Hospitals and Clinics ($bn) 0.41 0.45 0.51 0.56 0.63 0.70 11.0%
AGR (%) 11.1% 11.4% 11.6% 11.6% 11.7% 11.5%
Pharmaceutical Company
($bn)
1.37 1.51 1.66 1.82 2.01 2.20 9.4%
AGR (%) 9.5% 9.8% 10.0% 10.0% 10.1% 9.9%
Others ($bn) 0.13 0.14 0.16 0.17 0.19 0.21 9.6%
AGR (%) 9.7% 9.9% 10.1% 10.0% 10.0% 9.8%
Total ($bn) 2.18 2.40 2.64 2.92 3.22 3.55 9.8%
AGR (%) 9.8% 10.1% 10.3% 10.3% 10.4% 10.2%
CAGR 2018-2023 (%) 9.3% CAGR 2023-2028
(%)
10.3%
CAGR 2018-2028 (%) 9.8%
Source: Visiongain 2018
Figure 14.12 Middle East & Africa Genomics Market by End-User: Revenue
($bn), 2018-2028
Source: Visiongain 2018
0.00
0.50
1.00
1.50
2.00
2.50
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Revenue($bn)
Year
Research Centers Hospitals and Clinics Pharnaceutical Company Others

2. www.visiongain.com/pharma Page122
Global Genomics Market Report 2018-2028:Sequencing, Microarray, PCR, Nucleic
Acid Extraction and Purification, Diagnostic Test, Genetic Test, Newborn Screening,
Preimplantation Testing, Prenatal Testing, Carrier Testing, Molecular Test, Chromosomal Test,
Biochemical Test, Diagnostic, Drug Discovery, Precision Medicine, Research Centers, Hospitals
and Clinics, Pharmaceutical Companies and Others
Figure 45.5 Market Attractiveness Analysis by Application: Market Share (%),
CAGR (%)
Source: Visiongain 2018
Figure 15.6 Market Attractiveness Analysis by End-User: Market Share (%),
CAGR (%)
Source: Visiongain 2018
Diagnostic
Drug Discovery
Precision Medicine
Others
0%
5%
10%
15%
20%
25%
30%
35%
40%
45%
9% 9% 10% 10% 11% 11% 12%
MarketShare(%)
CAGR
Market Attractiveness Analysis by Application
Research Centers
Hospitals and Clinics
Pharnaceutical
Company
Others
-10%
0%
10%
20%
30%
40%
50%
60%
70%
80%
0% 2% 4% 6% 8% 10% 12% 14%
MarketShare(%)
CAGR (%)
Market Attractiveness Analysis by End-User

3. www.visiongain.com/pharma Page157
Global Genomics Market Report 2018-2028:Sequencing, Microarray, PCR, Nucleic
Acid Extraction and Purification, Diagnostic Test, Genetic Test, Newborn Screening,
Preimplantation Testing, Prenatal Testing, Carrier Testing, Molecular Test, Chromosomal Test,
Biochemical Test, Diagnostic, Drug Discovery, Precision Medicine, Research Centers, Hospitals
and Clinics, Pharmaceutical Companies and Others
Eurofins Scientific Sales Analysis
Eurofins Scientific recorded revenue of € 2,971 Mn in 2017
Figure 16.15 Eurofins Scientific Sales Analysis (€m), 2015 - 2017
Source: Company’s Website, Visiongain 2018
Figure 16.16 Eurofins Scientific Sales Analysis by Geography (% Share), 2017
Source: Company’s Website, Visiongain 2018
0
500
1,000
1,500
2,000
2,500
3,000
3,500
2017 2016 2015
Revenue€m
Year
Revenue
30.4%
22.8%11.5%
7.2%
7.1%
5.4%
15.6% North America
France
Germany
Benelux
Nordic Region
UK & Ireland
Others